Broad coverage, rising losses: Inside the growing D&O challenge for VCs

For years, venture capital (VC) firms were considered relatively benign risks in the directors and officers (D&O) insurance market.

Compared to traditional buyout private equity, VCs generated fewer claims, fewer losses, and generally enjoyed broad coverage, healthy capacity, and competitive pricing. READ MORE